000725900 000__ 03493cam\a2200469Ii\4500
000725900 001__ 725900
000725900 005__ 20230306140703.0
000725900 006__ m\\\\\o\\d\\\\\\\\
000725900 007__ cr\cn\nnnunnun
000725900 008__ 150305s2015\\\\sz\a\\\\ob\\\\001\0\eng\d
000725900 019__ $$a908098094
000725900 020__ $$a9783319111612$$qelectronic book
000725900 020__ $$a3319111612$$qelectronic book
000725900 020__ $$z9783319111605
000725900 0247_ $$a10.1007/978-3-319-11161-2$$2doi
000725900 035__ $$aSP(OCoLC)ocn904397961
000725900 035__ $$aSP(OCoLC)904397961$$z(OCoLC)908098094
000725900 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dE7B$$dIDEBK$$dUPM$$dCOO$$dYDXCP$$dOCLCF$$dOCLCO$$dEBLCP
000725900 049__ $$aISEA
000725900 050_4 $$aRC632.L5
000725900 08204 $$a616.3997$$223
000725900 24500 $$aLipid management$$h[electronic resource] :$$bfrom basics to clinic /$$cHussein Yassine, editor.
000725900 264_1 $$aCham :$$bSpringer,$$c[2015]
000725900 264_4 $$c©2015
000725900 300__ $$a1 online resource :$$billustrations
000725900 336__ $$atext$$btxt$$2rdacontent
000725900 337__ $$acomputer$$bc$$2rdamedia
000725900 338__ $$aonline resource$$bcr$$2rdacarrier
000725900 504__ $$aIncludes bibliographical references and index.
000725900 5050_ $$aBasics of Lipoprotein Metabolism -- Genetics of Lipid Disorders -- Lipid and Inflammation in Atherosclerosis -- Dyslipidemia: Relationship to Insulin Resistance, Fatty Liver, and Sub-clinical atherosclerosis -- Is low HDL cholesterol a marker of a mediator of cardiovascular disease? -- Approach to the patient with lipid disorders -- The Effects of Diet in Hyperlipidemia -- Statins -- Non-alcoholic Fatty Liver Disease (NAFLD): The Lipid Disease of the Liver and the Effect of Statins -- Statins in Heart Failure -- Statins in Chronic Kidney Disease -- Non-statin therapies -- LDL Apheresis -- Dyslipidemia in HIV -- New and Emerging Lipid Therapies.
000725900 506__ $$aAccess limited to authorized users.
000725900 520__ $$aThis timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
000725900 650_0 $$aLipids$$xMetabolism.
000725900 650_0 $$aLipids$$xMetabolism$$xDisorders.
000725900 650_0 $$aHyperlipidemia.
000725900 650_0 $$aCholesterol$$xMetabolism.
000725900 7001_ $$aYassine, Hussein,$$eeditor.
000725900 77608 $$iPrint version:$$z9783319111605
000725900 852__ $$bebk
000725900 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-11161-2$$zOnline Access$$91397441.1
000725900 909CO $$ooai:library.usi.edu:725900$$pGLOBAL_SET
000725900 980__ $$aEBOOK
000725900 980__ $$aBIB
000725900 982__ $$aEbook
000725900 983__ $$aOnline
000725900 994__ $$a92$$bISE